AB
$256.46
-3.75
(-1.44%)
As of Sep 5, 2026, 2:45 PM EDT · cached
Price history
AbbVie (ABBV) is trading down at $256.46 (-1.44%) on NYSE/NASDAQ, as of the latest quote. It is a S&P 500 constituent in the Health Care sector.
Recent News (20)
-
AbbVie Closes $10.9 Billion Apogee Deal; Earnings Payoff Starts in 2032 AbbVie Closes $10.9 Billion Apogee Deal; Earnings Payoff Starts in 2032 TechStock²
-
Scotiabank Remains a Buy on AbbVie (ABBV) Scotiabank Remains a Buy on AbbVie (ABBV) The Globe and Mail
-
ABBV Stock Gains On Winning FDA Approval For Rare Blood Cancer Drug ABBV Stock Gains On Winning FDA Approval For Rare Blood Cancer Drug Stocktwits
-
-
AbbVie vs. Pfizer: Which Healthcare Stock Is a Better Buy in 2026? AbbVie vs. Pfizer: Which Healthcare Stock Is a Better Buy in 2026? The Motley Fool
-
-
AbbVie’s Humira Cash Cow Is Shrinking—Can Its Dividend Keep Growing?
AbbVie’s Humira Cash Cow Is Shrinking—Can Its Dividend Keep Growing?
-
AbbVie’s Humira Cash Cow Is Shrinking—Can Its Dividend Keep Growing? - 24/7 Wall St. AbbVie’s Humira Cash Cow Is Shrinking—Can Its Dividend Keep Growing? 24/7 Wall St.
-
-
-
ABBV Stock Quote Price and Forecast ABBV Stock Quote Price and Forecast CNN
-
-
-
-
-
-
-
-
-
More Health Care stocks
- AMGN Amgen
- BIIB Biogen
- GILD Gilead Sciences
- INCY Incyte
- MRNA Moderna
- REGN Regeneron Pharmaceuticals
- VRTX Vertex Pharmaceuticals
- A Agilent Technologies